SlideShare a Scribd company logo
DEFINITION
• Primary angle closure glaucoma is a type of
primary glaucoma(with no obvious systemic or
ocular cause) characterized by
occludable/closed angles leading to
obstruction of aqueous outflow resulting in
rise of intra ocular pressure, optic nerve
damage and visual field defects.
2
ANGLE OF ANTERIOR CHAMBER
• STRUCTURES
– Schwalbe’s line
– Trabecular meshwork
– Scleral spur
– Ciliary body band
– Root of iris
3
DRAINAGE OF AQUEOUS HUMOR
4
PRIMARY ANGLE CLOSURE
GLAUCOMA
EPIDEMIOLOGY
• PACG is the major cause of glaucoma blindness
worldwide.
• Age :- Average age at presentation 50-60 yrs
• Gender :- F > M, 4 : 1
• Race :-seen commonly in South-East Asian
population, Chinese and Eskimos
• Heredity :- mostly sporadic but may be inherited
AD/AR
– first degree relatives are at increased risk.
• Refractive error :- more common in
hypermetropes 5
Ocular risk factors
1. Shallow anterior chamber both
centrally and peripherally.
2. Decreased anterior chamber volume.
3. Short axial length of the globe.
4. Small corneal diameter.
6
Ocular risk factors
5.Decreased posterior corneal radius of
curvature
6.Anterior position of the lens with respect to
the ciliary body.
7.Increased curvature of the anterior surface &
thickness of lens 7
PATHOGENESIS
• It is incompletely understood.
» a. Iris–pupil obstruction (e.g., ‘pupillary block’)
» b. Ciliary body anomalies (e.g., ‘plateau iris syndrome’)
» c. Lens–pupil block (e.g., ‘phacomorphic block’ (swollen
lens or microspherophakia))
• Relative Pupillary block
• Normally the pressure in the post. chamber exceeds that in the ant.
chamber due to physiological degree of resistance at the pupil ,since the
iris rests posteriorly on the anterior lens capsule.
8
Anterior Iris Bowing
Simultaneous dilatation of the pupil renders the peripheral
iris more flaccid. The pupil block causes the pressure in the
Posterior Chamber to increase & peripheral iris bows
anteriorly
9
Iridocorneal contact
Eventually the iris touches the posterior corneal surface,
obstructing the angle and the IOP rises.
10
Precipitating factors
1. Factors that produce mydriasis
• Dim illumination
• Emotional stress(due to increased sympathetic tone)
• Drugs
– Mydriatic agents :
• cyclopentolate, tropicamide, atropine, homatropine.
– Antipsychotic agents
» Phenothiazines: e.g., perphenazine ,fluphenazine
» Anticonvulsants e.g., Topiramate
11
– Antidepressants
» Tricyclic agents: amitriptylene ,imipramine
» Non-tricyclic agents: fluoxetine
– Antiparkinsonian agents : Trihexyphenidryl
– Antispasmolytics : Propantheline ,Dicyclomine
– Sympathomimetic agents : Adrenaline (epinephrine),
ephedrine, phenylephrine.
12
CLASSIFICATION
A. Primary angle-closure disease
• Irido-trabecular contact is the final common pathway of
angle closure disease, obstructing aqueous outflow
1. New classification
Primary angle closure suspect/PACS
Primary angle closure/PAC
Primary angle-closure glaucoma/PACG
2. Old classification
Angle closure suspect
Intermittent (sub acute) angle closure
Acute angle closure
Chronic angle closure
Absolute angle closure 13
New classification of PACG
Primary angle closure suspect/PACS
Has occludable/narrow angles
Primary angle closure/PAC
Has occludable/narrow angles +
High IOP/Peripheral anterior synechiae/
Excessive trabecular meshwork
pigmentation
Primary angle-closure glaucoma/PACG
PAC+ Optic disc changes+ Visual field
defects
14
Gonioscopic grading of Angle
closure
• Several grading systems :- Shaffer’s, Spaeth’s,
Scheie’s.
• Shaffer’s grading
Grade Angle width configuration Chances of
closure
Structures visible
IV 35°-45° Wide open Nil SL,TM,SS,CBB
III 20°-35° Open angle Nil SL,TM,SS
II 20° Moderately open Possible SL,TM
I 10° Very narrow Highly likely SL only
0 0° Closed Closed None
15
---------
Grade
IV
III
II
I
0
16
Van Herrick’s grading
17
Tests for Angle closure
• Eclipse test : uses flash light to make a rough
assessment of angle depth
• Provocative tests for PAC suspects
Prone- darkroom test: An increase in IOP of more
than 8mm Hg after one hour suggests PAC
Mydriatic provocative test: Not preferred now
Fincham’s Test: Also known as stenopaeic-slit test.
Glaucomatous halos remain intact , whereas
halos due to cataract are broken up into segments
18
PRIMARY ANGLE CLOSURE GLAUCOMA SUSPECT
• Also known as Latent PACG
• Essentially, the term implies
an anatomically predisposed
eye.
• Symptoms :- absent
• Signs :
– Axial AC depth is < normal
& iris lens diaphragm is
convex
– Close proximity of the iris
to the cornea
– Gonioscopy :- occludable
angle(grade 1 or 0)
without indentation in at
least 3 quadrants. 19
•Clinical course without
treatment may be:
IOP may remain normal
Acute or sub acute angle
closure may ensue
Chronic angle closure may
develop, without acute or
sub acute stages.
20
• Treatment
• Without treatment , risk of an acute pressure rise during the next
5 years is about 50 %.
• The need to treat is based on following criteria:-
– If one eye has had acute or subacute angle closure, then
fellow eye should undergo prophylactic peripheral laser
iridotomy (Laser PI)
– If both eyes have occludable angles, laser PI may be done
21
INTERMITTENT(SUBACUTE)PRIMARY ANGLE CLOSURE
GLAUCOMA
• A form of pupillary block glaucoma, which may not have
any recognizable symptoms.
• Occurs in a predisposed eye with an occludable angle in
association with intermittent pupillary block.
• Precipitating factors :- physiological mydriasis , or
physiological shallowing of AC when patient assumes a
prone or semi prone position ;emotional stress.
22
• Symptoms
– Characteristic h/o transient blurring of vision with haloes
around lights
– Ocular discomfort or frontal headache
– Attacks are recurrent and are usually broken after 1-2 hrs by
physiological miosis.
• Signs
– During an attack , eye is usually white
– In between attacks, eye looks normal although the angle is
narrow.
• Clinical course
– Without treatment is variable
• Some eyes develop an acute attack
• Others chronic angle closure
• Treatment:- Prophylactic laser PeripheraI Iridotomy(PI) 23
ACUTE PRIMARY ANGLE CLOSURE GLAUCOMA
• Sight threatening emergency
• Painful loss of vision due to sudden and total
closure of the angle.
• VA usually 6/60-Hand Movements.
• IOP is usually very high (40–70 mmHg).
24
Findings during an acute attack of angle-closure glaucoma
• Two of the following symptom sets:
– Periorbital or ocular pain
– Diminished vision
– Specific history of rainbow haloes with blurred vision
• IOP > 21 mmHg plus three of the following
findings:
– Ciliary flush (perilimbal conjunctival hyperemia)
– Corneal edema (epithelial,stromal)
– Shallow anterior chamber
25
Findings during an acute attack of angle-closure glaucoma
– Anterior chamber cell and flare
– Mid-dilated ,vertically oval and sluggishly reactive
pupil
– Closed angle on gonioscopy
– Hyperemic and swollen optic disc(due to
decreased axoplasmic outflow)
– Constricted visual fields
26
• MANAGEMENT
• Patient comfort ,lowering of the IOP and to break acute
attack— main priorities.
• A. Immediate medical treatment
1. Patient should lie supine to allow the lens to shift
posteriorly.
2. Acetazolamide 500 mg orally(if there is no vomiting).
or I.V Mannitol 20% 1-2 g/kg over 1 hour (rule out
contraindications)
3.Topical
Prednisolone or dexamethasone q.i.d (if AC reaction)
Timolol (if there is no contraindication).
4. Analgesia and emetics as required. 27
• B. Subsequent medical treatment
Pilocarpine 2% q.i.d. to the affected eye and 1% q.i.d. to
the fellow eye.
Topical steroids (prednisolone 1% or dexamethasone 0.1%)
q.i.d. if the eye is acutely inflamed.
Timolol 0.5% b.d.,
and oral acetazolamide 250 mg q.i.d. may be required.
• If the above measures fail:
– Laser iridotomy or iridoplasty after clearing corneal oedema with
glycerol.
– Surgical options in resistant cases include lens extraction,
goniosynechiolysis, trabeculectomy and cycloablation.
28
• Findings suggestive of previous episodes of acute
angle closure glaucoma
– Descemets Membrane folds
– Fine pigment granules on corneal endothelium
– Peripheral anterior synechiae
– Posterior synechiae
– Glaucomflecken
– Sectoral/generalized iris atrophy
– Fixed and semi dilated pupil
– Optic nerve cupping &/or pallor
– Gonioscopy shows narrow angle
or PAS
– Visual field loss
29
Chronic angle closure glaucoma
• Visual Acuity is normal unless damage is
advanced.
• Anterior chamber is shallower in pupillary
block than non-pupillary block.
• Optic nerve signs depend on severity of
damage.
• IOP elevation may be only intermittent.
• Gonioscopic abnormalities-Peripheral
Anterior Synechiae, narrow angle,
pigmentation of Schwalbe’s line.
30
Treatment of chronic angle closure
• Medical treatment is similar to that of POAG
• Prostaglandin/Prostamides
Latanoprost, Bimatoprost, Travoprost
• Beta blockers
Timolol maleate, Betaxolol
• Carbonic anhydrase inhibitors
Dorzolamide, Brinzolamide
• Sympathomimetics
Brimonidine, Apraclonidine
• Parasmpathomimetics
Pilocarpine
• Oral carbonic anhydrase inhibitors
Acetazolamide, Methazolamide
31
Treatment of chronic angle closure
• Laser Peripheral Iridotomy (PI) in affected eye
along with Prophylactic PI in fellow eye
32
Laser Peripheral Iridotomy
• Complications of laser therapy
1. Bleeding
2. IOP elevation
3. Iritis
4. Corneal burns
5. Lens opacities
6. Glare and diplopia
33
• Surgical treatment
Trabeculectomy (filtering surgery) is the
surgical procedure of choice
• Success:- 87- 100 % with multiple operations
• Complications:-
– Flat AC, hypotony
– Bleb related infections
– Cyclodialysis
• PATIENTS REQUIRE REGULAR AND LIFE LONG
FOLLOW UP
34
Absolute glaucoma
• Is the final/last stage of PACG
• Clinical features:
 Painful blind eye
Perilimbal reddish blue zone, due to dilated
anterior ciliary veins
Cornea gradually becomes hazy, insensitive
with bullous keratopathy and filamentary
keratitis
Anterior chamber is very shallow/flat
35
Clinical features of absolute glaucoma
 Iris is usually atrophic
Pupil is fixed and dilated
Glaucomatous optic atrophy of the optic disc
High IOP
36
Management of absolute glaucoma
• Cycloablation/destruction of the secretory
ciliary epithelium
 Cyclophotocoagulation
 Cyclocryotherapy
 Cyclodiathermy
• Rarely
• Retrobulbar alcohol injection
• Enucleation of eyeball
37
Complications
• Corneal ulceration
• Staphyloma formation (Ciliary/Equatorial)
• Atrophic bulbi (Shrunken eye)
38
39

More Related Content

Similar to acg_final_12_4_18.pptx

Glaucoma-Presentation new (2).pptx
Glaucoma-Presentation new (2).pptxGlaucoma-Presentation new (2).pptx
Glaucoma-Presentation new (2).pptx
yashabandil155
 
Glaucoma
GlaucomaGlaucoma
glaucoma
glaucomaglaucoma
glaucoma
gebru getaye
 
Gradual vision loss
Gradual vision lossGradual vision loss
Gradual vision loss
alijafer99
 
Pacg 04.05.16 - dr.a.r.rajalakshmi
Pacg  04.05.16 - dr.a.r.rajalakshmiPacg  04.05.16 - dr.a.r.rajalakshmi
Pacg 04.05.16 - dr.a.r.rajalakshmi
Srikanth K
 
ophthalmology.Glaucoma 2nd lect.(dr.ali)
ophthalmology.Glaucoma 2nd lect.(dr.ali)ophthalmology.Glaucoma 2nd lect.(dr.ali)
ophthalmology.Glaucoma 2nd lect.(dr.ali)
student
 
Secondary-glaucoma-Final.pptx
Secondary-glaucoma-Final.pptxSecondary-glaucoma-Final.pptx
Secondary-glaucoma-Final.pptx
Harshika Malik
 
Primary Angle Closure Glaucoma- Saral
Primary Angle Closure Glaucoma- SaralPrimary Angle Closure Glaucoma- Saral
Primary Angle Closure Glaucoma- Saral
Saral Lamichhane
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
Hasan Arafat
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
Sujata Jha
 
Glaucoma RCSI
Glaucoma RCSIGlaucoma RCSI
Glaucoma RCSI
OphthalmicDocs Chiong
 
Glaucoma word document
Glaucoma word document Glaucoma word document
Glaucoma word document
ayesharuqsar
 
Poag 28.04.16 - dr.a.r.rajalakshmi
Poag 28.04.16 - dr.a.r.rajalakshmiPoag 28.04.16 - dr.a.r.rajalakshmi
Poag 28.04.16 - dr.a.r.rajalakshmi
ophthalmgmcri
 
Acute Rise in IOP (Dr. Rasha, senior resident of ophthalmology)
Acute Rise in IOP (Dr. Rasha, senior resident of ophthalmology)Acute Rise in IOP (Dr. Rasha, senior resident of ophthalmology)
Acute Rise in IOP (Dr. Rasha, senior resident of ophthalmology)
Hind Safwat
 
Glaucoma 2nd class
Glaucoma 2nd classGlaucoma 2nd class
Glaucoma 2nd class
DrAliReja
 
GLAUCOMA.ppt
GLAUCOMA.pptGLAUCOMA.ppt
GLAUCOMA.ppt
minkmin91
 
Primary open angle glaucoma
Primary open angle glaucomaPrimary open angle glaucoma
Primary open angle glaucoma
Amr Mounir
 
Pacg
PacgPacg
POAG AND PACG
POAG AND PACGPOAG AND PACG
POAG AND PACG
Jayendra Jha
 
CONGENITAL GLAUCOMA - USMAN.pptx
CONGENITAL GLAUCOMA - USMAN.pptxCONGENITAL GLAUCOMA - USMAN.pptx
CONGENITAL GLAUCOMA - USMAN.pptx
usmantariq170351
 

Similar to acg_final_12_4_18.pptx (20)

Glaucoma-Presentation new (2).pptx
Glaucoma-Presentation new (2).pptxGlaucoma-Presentation new (2).pptx
Glaucoma-Presentation new (2).pptx
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
glaucoma
glaucomaglaucoma
glaucoma
 
Gradual vision loss
Gradual vision lossGradual vision loss
Gradual vision loss
 
Pacg 04.05.16 - dr.a.r.rajalakshmi
Pacg  04.05.16 - dr.a.r.rajalakshmiPacg  04.05.16 - dr.a.r.rajalakshmi
Pacg 04.05.16 - dr.a.r.rajalakshmi
 
ophthalmology.Glaucoma 2nd lect.(dr.ali)
ophthalmology.Glaucoma 2nd lect.(dr.ali)ophthalmology.Glaucoma 2nd lect.(dr.ali)
ophthalmology.Glaucoma 2nd lect.(dr.ali)
 
Secondary-glaucoma-Final.pptx
Secondary-glaucoma-Final.pptxSecondary-glaucoma-Final.pptx
Secondary-glaucoma-Final.pptx
 
Primary Angle Closure Glaucoma- Saral
Primary Angle Closure Glaucoma- SaralPrimary Angle Closure Glaucoma- Saral
Primary Angle Closure Glaucoma- Saral
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
Glaucoma RCSI
Glaucoma RCSIGlaucoma RCSI
Glaucoma RCSI
 
Glaucoma word document
Glaucoma word document Glaucoma word document
Glaucoma word document
 
Poag 28.04.16 - dr.a.r.rajalakshmi
Poag 28.04.16 - dr.a.r.rajalakshmiPoag 28.04.16 - dr.a.r.rajalakshmi
Poag 28.04.16 - dr.a.r.rajalakshmi
 
Acute Rise in IOP (Dr. Rasha, senior resident of ophthalmology)
Acute Rise in IOP (Dr. Rasha, senior resident of ophthalmology)Acute Rise in IOP (Dr. Rasha, senior resident of ophthalmology)
Acute Rise in IOP (Dr. Rasha, senior resident of ophthalmology)
 
Glaucoma 2nd class
Glaucoma 2nd classGlaucoma 2nd class
Glaucoma 2nd class
 
GLAUCOMA.ppt
GLAUCOMA.pptGLAUCOMA.ppt
GLAUCOMA.ppt
 
Primary open angle glaucoma
Primary open angle glaucomaPrimary open angle glaucoma
Primary open angle glaucoma
 
Pacg
PacgPacg
Pacg
 
POAG AND PACG
POAG AND PACGPOAG AND PACG
POAG AND PACG
 
CONGENITAL GLAUCOMA - USMAN.pptx
CONGENITAL GLAUCOMA - USMAN.pptxCONGENITAL GLAUCOMA - USMAN.pptx
CONGENITAL GLAUCOMA - USMAN.pptx
 

More from Harshika Malik

artifical intelligence in ophthalmology.pptx
artifical intelligence in ophthalmology.pptxartifical intelligence in ophthalmology.pptx
artifical intelligence in ophthalmology.pptx
Harshika Malik
 
Retinal Dystrophy.pptx vvvvvvvvvvvvvvvvv
Retinal Dystrophy.pptx vvvvvvvvvvvvvvvvvRetinal Dystrophy.pptx vvvvvvvvvvvvvvvvv
Retinal Dystrophy.pptx vvvvvvvvvvvvvvvvv
Harshika Malik
 
ECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptx
ECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptxECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptx
ECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptx
Harshika Malik
 
EPISCLERITIS AND SCLERITIS.pptx bbbbbbbb
EPISCLERITIS AND SCLERITIS.pptx bbbbbbbbEPISCLERITIS AND SCLERITIS.pptx bbbbbbbb
EPISCLERITIS AND SCLERITIS.pptx bbbbbbbb
Harshika Malik
 
PENETRATING KERATOPLASTY - Cmmmmopy.pptx
PENETRATING KERATOPLASTY - Cmmmmopy.pptxPENETRATING KERATOPLASTY - Cmmmmopy.pptx
PENETRATING KERATOPLASTY - Cmmmmopy.pptx
Harshika Malik
 
LAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvv
LAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvvLAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvv
LAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvv
Harshika Malik
 
rop.pptx
rop.pptxrop.pptx
rop.pptx
Harshika Malik
 
TED.pptx
TED.pptxTED.pptx
TED.pptx
Harshika Malik
 
proptosis.pptx
proptosis.pptxproptosis.pptx
proptosis.pptx
Harshika Malik
 
Mechanical_ocular_trauma.pptx
Mechanical_ocular_trauma.pptxMechanical_ocular_trauma.pptx
Mechanical_ocular_trauma.pptx
Harshika Malik
 
retinal_detachment 4.pptx
retinal_detachment 4.pptxretinal_detachment 4.pptx
retinal_detachment 4.pptx
Harshika Malik
 
squint copy.pptx
squint copy.pptxsquint copy.pptx
squint copy.pptx
Harshika Malik
 
diabetic_retinopathy copy.pptx
diabetic_retinopathy copy.pptxdiabetic_retinopathy copy.pptx
diabetic_retinopathy copy.pptx
Harshika Malik
 
830_Optic_nerve_final copy 2.pptx
830_Optic_nerve_final copy 2.pptx830_Optic_nerve_final copy 2.pptx
830_Optic_nerve_final copy 2.pptx
Harshika Malik
 
retinoblastoma 2.pptx
retinoblastoma 2.pptxretinoblastoma 2.pptx
retinoblastoma 2.pptx
Harshika Malik
 
approach to padiatric cataract 2.pptx
approach to padiatric cataract 2.pptxapproach to padiatric cataract 2.pptx
approach to padiatric cataract 2.pptx
Harshika Malik
 
aion.pptx
aion.pptxaion.pptx
aion.pptx
Harshika Malik
 
lacrimal apparatus.pptx
lacrimal apparatus.pptxlacrimal apparatus.pptx
lacrimal apparatus.pptx
Harshika Malik
 
catarcact-ug1 2.pptx
catarcact-ug1 2.pptxcatarcact-ug1 2.pptx
catarcact-ug1 2.pptx
Harshika Malik
 
1167_Anterior-Uveitis 2.pptx
1167_Anterior-Uveitis 2.pptx1167_Anterior-Uveitis 2.pptx
1167_Anterior-Uveitis 2.pptx
Harshika Malik
 

More from Harshika Malik (20)

artifical intelligence in ophthalmology.pptx
artifical intelligence in ophthalmology.pptxartifical intelligence in ophthalmology.pptx
artifical intelligence in ophthalmology.pptx
 
Retinal Dystrophy.pptx vvvvvvvvvvvvvvvvv
Retinal Dystrophy.pptx vvvvvvvvvvvvvvvvvRetinal Dystrophy.pptx vvvvvvvvvvvvvvvvv
Retinal Dystrophy.pptx vvvvvvvvvvvvvvvvv
 
ECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptx
ECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptxECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptx
ECTROPION^JENTROPION AND THEIR MANAGEMENT 2.pptx
 
EPISCLERITIS AND SCLERITIS.pptx bbbbbbbb
EPISCLERITIS AND SCLERITIS.pptx bbbbbbbbEPISCLERITIS AND SCLERITIS.pptx bbbbbbbb
EPISCLERITIS AND SCLERITIS.pptx bbbbbbbb
 
PENETRATING KERATOPLASTY - Cmmmmopy.pptx
PENETRATING KERATOPLASTY - Cmmmmopy.pptxPENETRATING KERATOPLASTY - Cmmmmopy.pptx
PENETRATING KERATOPLASTY - Cmmmmopy.pptx
 
LAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvv
LAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvvLAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvv
LAMELLAR KERATOPLASTY.pptx vvvvvvvvvvvvvv
 
rop.pptx
rop.pptxrop.pptx
rop.pptx
 
TED.pptx
TED.pptxTED.pptx
TED.pptx
 
proptosis.pptx
proptosis.pptxproptosis.pptx
proptosis.pptx
 
Mechanical_ocular_trauma.pptx
Mechanical_ocular_trauma.pptxMechanical_ocular_trauma.pptx
Mechanical_ocular_trauma.pptx
 
retinal_detachment 4.pptx
retinal_detachment 4.pptxretinal_detachment 4.pptx
retinal_detachment 4.pptx
 
squint copy.pptx
squint copy.pptxsquint copy.pptx
squint copy.pptx
 
diabetic_retinopathy copy.pptx
diabetic_retinopathy copy.pptxdiabetic_retinopathy copy.pptx
diabetic_retinopathy copy.pptx
 
830_Optic_nerve_final copy 2.pptx
830_Optic_nerve_final copy 2.pptx830_Optic_nerve_final copy 2.pptx
830_Optic_nerve_final copy 2.pptx
 
retinoblastoma 2.pptx
retinoblastoma 2.pptxretinoblastoma 2.pptx
retinoblastoma 2.pptx
 
approach to padiatric cataract 2.pptx
approach to padiatric cataract 2.pptxapproach to padiatric cataract 2.pptx
approach to padiatric cataract 2.pptx
 
aion.pptx
aion.pptxaion.pptx
aion.pptx
 
lacrimal apparatus.pptx
lacrimal apparatus.pptxlacrimal apparatus.pptx
lacrimal apparatus.pptx
 
catarcact-ug1 2.pptx
catarcact-ug1 2.pptxcatarcact-ug1 2.pptx
catarcact-ug1 2.pptx
 
1167_Anterior-Uveitis 2.pptx
1167_Anterior-Uveitis 2.pptx1167_Anterior-Uveitis 2.pptx
1167_Anterior-Uveitis 2.pptx
 

Recently uploaded

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
chandankumarsmartiso
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 

Recently uploaded (20)

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 

acg_final_12_4_18.pptx

  • 1.
  • 2. DEFINITION • Primary angle closure glaucoma is a type of primary glaucoma(with no obvious systemic or ocular cause) characterized by occludable/closed angles leading to obstruction of aqueous outflow resulting in rise of intra ocular pressure, optic nerve damage and visual field defects. 2
  • 3. ANGLE OF ANTERIOR CHAMBER • STRUCTURES – Schwalbe’s line – Trabecular meshwork – Scleral spur – Ciliary body band – Root of iris 3
  • 5. PRIMARY ANGLE CLOSURE GLAUCOMA EPIDEMIOLOGY • PACG is the major cause of glaucoma blindness worldwide. • Age :- Average age at presentation 50-60 yrs • Gender :- F > M, 4 : 1 • Race :-seen commonly in South-East Asian population, Chinese and Eskimos • Heredity :- mostly sporadic but may be inherited AD/AR – first degree relatives are at increased risk. • Refractive error :- more common in hypermetropes 5
  • 6. Ocular risk factors 1. Shallow anterior chamber both centrally and peripherally. 2. Decreased anterior chamber volume. 3. Short axial length of the globe. 4. Small corneal diameter. 6
  • 7. Ocular risk factors 5.Decreased posterior corneal radius of curvature 6.Anterior position of the lens with respect to the ciliary body. 7.Increased curvature of the anterior surface & thickness of lens 7
  • 8. PATHOGENESIS • It is incompletely understood. » a. Iris–pupil obstruction (e.g., ‘pupillary block’) » b. Ciliary body anomalies (e.g., ‘plateau iris syndrome’) » c. Lens–pupil block (e.g., ‘phacomorphic block’ (swollen lens or microspherophakia)) • Relative Pupillary block • Normally the pressure in the post. chamber exceeds that in the ant. chamber due to physiological degree of resistance at the pupil ,since the iris rests posteriorly on the anterior lens capsule. 8
  • 9. Anterior Iris Bowing Simultaneous dilatation of the pupil renders the peripheral iris more flaccid. The pupil block causes the pressure in the Posterior Chamber to increase & peripheral iris bows anteriorly 9
  • 10. Iridocorneal contact Eventually the iris touches the posterior corneal surface, obstructing the angle and the IOP rises. 10
  • 11. Precipitating factors 1. Factors that produce mydriasis • Dim illumination • Emotional stress(due to increased sympathetic tone) • Drugs – Mydriatic agents : • cyclopentolate, tropicamide, atropine, homatropine. – Antipsychotic agents » Phenothiazines: e.g., perphenazine ,fluphenazine » Anticonvulsants e.g., Topiramate 11
  • 12. – Antidepressants » Tricyclic agents: amitriptylene ,imipramine » Non-tricyclic agents: fluoxetine – Antiparkinsonian agents : Trihexyphenidryl – Antispasmolytics : Propantheline ,Dicyclomine – Sympathomimetic agents : Adrenaline (epinephrine), ephedrine, phenylephrine. 12
  • 13. CLASSIFICATION A. Primary angle-closure disease • Irido-trabecular contact is the final common pathway of angle closure disease, obstructing aqueous outflow 1. New classification Primary angle closure suspect/PACS Primary angle closure/PAC Primary angle-closure glaucoma/PACG 2. Old classification Angle closure suspect Intermittent (sub acute) angle closure Acute angle closure Chronic angle closure Absolute angle closure 13
  • 14. New classification of PACG Primary angle closure suspect/PACS Has occludable/narrow angles Primary angle closure/PAC Has occludable/narrow angles + High IOP/Peripheral anterior synechiae/ Excessive trabecular meshwork pigmentation Primary angle-closure glaucoma/PACG PAC+ Optic disc changes+ Visual field defects 14
  • 15. Gonioscopic grading of Angle closure • Several grading systems :- Shaffer’s, Spaeth’s, Scheie’s. • Shaffer’s grading Grade Angle width configuration Chances of closure Structures visible IV 35°-45° Wide open Nil SL,TM,SS,CBB III 20°-35° Open angle Nil SL,TM,SS II 20° Moderately open Possible SL,TM I 10° Very narrow Highly likely SL only 0 0° Closed Closed None 15
  • 18. Tests for Angle closure • Eclipse test : uses flash light to make a rough assessment of angle depth • Provocative tests for PAC suspects Prone- darkroom test: An increase in IOP of more than 8mm Hg after one hour suggests PAC Mydriatic provocative test: Not preferred now Fincham’s Test: Also known as stenopaeic-slit test. Glaucomatous halos remain intact , whereas halos due to cataract are broken up into segments 18
  • 19. PRIMARY ANGLE CLOSURE GLAUCOMA SUSPECT • Also known as Latent PACG • Essentially, the term implies an anatomically predisposed eye. • Symptoms :- absent • Signs : – Axial AC depth is < normal & iris lens diaphragm is convex – Close proximity of the iris to the cornea – Gonioscopy :- occludable angle(grade 1 or 0) without indentation in at least 3 quadrants. 19
  • 20. •Clinical course without treatment may be: IOP may remain normal Acute or sub acute angle closure may ensue Chronic angle closure may develop, without acute or sub acute stages. 20
  • 21. • Treatment • Without treatment , risk of an acute pressure rise during the next 5 years is about 50 %. • The need to treat is based on following criteria:- – If one eye has had acute or subacute angle closure, then fellow eye should undergo prophylactic peripheral laser iridotomy (Laser PI) – If both eyes have occludable angles, laser PI may be done 21
  • 22. INTERMITTENT(SUBACUTE)PRIMARY ANGLE CLOSURE GLAUCOMA • A form of pupillary block glaucoma, which may not have any recognizable symptoms. • Occurs in a predisposed eye with an occludable angle in association with intermittent pupillary block. • Precipitating factors :- physiological mydriasis , or physiological shallowing of AC when patient assumes a prone or semi prone position ;emotional stress. 22
  • 23. • Symptoms – Characteristic h/o transient blurring of vision with haloes around lights – Ocular discomfort or frontal headache – Attacks are recurrent and are usually broken after 1-2 hrs by physiological miosis. • Signs – During an attack , eye is usually white – In between attacks, eye looks normal although the angle is narrow. • Clinical course – Without treatment is variable • Some eyes develop an acute attack • Others chronic angle closure • Treatment:- Prophylactic laser PeripheraI Iridotomy(PI) 23
  • 24. ACUTE PRIMARY ANGLE CLOSURE GLAUCOMA • Sight threatening emergency • Painful loss of vision due to sudden and total closure of the angle. • VA usually 6/60-Hand Movements. • IOP is usually very high (40–70 mmHg). 24
  • 25. Findings during an acute attack of angle-closure glaucoma • Two of the following symptom sets: – Periorbital or ocular pain – Diminished vision – Specific history of rainbow haloes with blurred vision • IOP > 21 mmHg plus three of the following findings: – Ciliary flush (perilimbal conjunctival hyperemia) – Corneal edema (epithelial,stromal) – Shallow anterior chamber 25
  • 26. Findings during an acute attack of angle-closure glaucoma – Anterior chamber cell and flare – Mid-dilated ,vertically oval and sluggishly reactive pupil – Closed angle on gonioscopy – Hyperemic and swollen optic disc(due to decreased axoplasmic outflow) – Constricted visual fields 26
  • 27. • MANAGEMENT • Patient comfort ,lowering of the IOP and to break acute attack— main priorities. • A. Immediate medical treatment 1. Patient should lie supine to allow the lens to shift posteriorly. 2. Acetazolamide 500 mg orally(if there is no vomiting). or I.V Mannitol 20% 1-2 g/kg over 1 hour (rule out contraindications) 3.Topical Prednisolone or dexamethasone q.i.d (if AC reaction) Timolol (if there is no contraindication). 4. Analgesia and emetics as required. 27
  • 28. • B. Subsequent medical treatment Pilocarpine 2% q.i.d. to the affected eye and 1% q.i.d. to the fellow eye. Topical steroids (prednisolone 1% or dexamethasone 0.1%) q.i.d. if the eye is acutely inflamed. Timolol 0.5% b.d., and oral acetazolamide 250 mg q.i.d. may be required. • If the above measures fail: – Laser iridotomy or iridoplasty after clearing corneal oedema with glycerol. – Surgical options in resistant cases include lens extraction, goniosynechiolysis, trabeculectomy and cycloablation. 28
  • 29. • Findings suggestive of previous episodes of acute angle closure glaucoma – Descemets Membrane folds – Fine pigment granules on corneal endothelium – Peripheral anterior synechiae – Posterior synechiae – Glaucomflecken – Sectoral/generalized iris atrophy – Fixed and semi dilated pupil – Optic nerve cupping &/or pallor – Gonioscopy shows narrow angle or PAS – Visual field loss 29
  • 30. Chronic angle closure glaucoma • Visual Acuity is normal unless damage is advanced. • Anterior chamber is shallower in pupillary block than non-pupillary block. • Optic nerve signs depend on severity of damage. • IOP elevation may be only intermittent. • Gonioscopic abnormalities-Peripheral Anterior Synechiae, narrow angle, pigmentation of Schwalbe’s line. 30
  • 31. Treatment of chronic angle closure • Medical treatment is similar to that of POAG • Prostaglandin/Prostamides Latanoprost, Bimatoprost, Travoprost • Beta blockers Timolol maleate, Betaxolol • Carbonic anhydrase inhibitors Dorzolamide, Brinzolamide • Sympathomimetics Brimonidine, Apraclonidine • Parasmpathomimetics Pilocarpine • Oral carbonic anhydrase inhibitors Acetazolamide, Methazolamide 31
  • 32. Treatment of chronic angle closure • Laser Peripheral Iridotomy (PI) in affected eye along with Prophylactic PI in fellow eye 32
  • 33. Laser Peripheral Iridotomy • Complications of laser therapy 1. Bleeding 2. IOP elevation 3. Iritis 4. Corneal burns 5. Lens opacities 6. Glare and diplopia 33
  • 34. • Surgical treatment Trabeculectomy (filtering surgery) is the surgical procedure of choice • Success:- 87- 100 % with multiple operations • Complications:- – Flat AC, hypotony – Bleb related infections – Cyclodialysis • PATIENTS REQUIRE REGULAR AND LIFE LONG FOLLOW UP 34
  • 35. Absolute glaucoma • Is the final/last stage of PACG • Clinical features:  Painful blind eye Perilimbal reddish blue zone, due to dilated anterior ciliary veins Cornea gradually becomes hazy, insensitive with bullous keratopathy and filamentary keratitis Anterior chamber is very shallow/flat 35
  • 36. Clinical features of absolute glaucoma  Iris is usually atrophic Pupil is fixed and dilated Glaucomatous optic atrophy of the optic disc High IOP 36
  • 37. Management of absolute glaucoma • Cycloablation/destruction of the secretory ciliary epithelium  Cyclophotocoagulation  Cyclocryotherapy  Cyclodiathermy • Rarely • Retrobulbar alcohol injection • Enucleation of eyeball 37
  • 38. Complications • Corneal ulceration • Staphyloma formation (Ciliary/Equatorial) • Atrophic bulbi (Shrunken eye) 38
  • 39. 39

Editor's Notes

  1. 1st-10 Sibling 4